148 related articles for article (PubMed ID: 2166255)
21. Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: pharmacological characterization.
Lysko PG; Cox JA; Vigano MA; Henneberry RC
Brain Res; 1989 Oct; 499(2):258-66. PubMed ID: 2572298
[TBL] [Abstract][Full Text] [Related]
22. Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors.
Rao TS; Kim HS; Lehmann J; Martin LL; Wood PL
Neuropharmacology; 1990 Mar; 29(3):225-30. PubMed ID: 2158000
[TBL] [Abstract][Full Text] [Related]
23. Release of [3H]norepinephrine from rat hippocampal slices by N-methyl-D-aspartate: comparison of the inhibitory effects of Mg2+ and MK-801.
Schmidt CJ; Taylor VL
Eur J Pharmacol; 1988 Oct; 156(1):111-20. PubMed ID: 2850205
[TBL] [Abstract][Full Text] [Related]
24. Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine.
Ohmori T; Abekawa T; Muraki A; Koyama T
Pharmacol Biochem Behav; 1994 Jul; 48(3):587-91. PubMed ID: 7938110
[TBL] [Abstract][Full Text] [Related]
25. Antinociception induced by 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1- phosphonic acid (CPP), an N-methyl-D-aspartate (NMDA) competitive antagonist, plus 6,7-dinitroquinoxaline-2,3-dione (DNQX), a non-NMDA antagonist, differs from that induced by MK-801 plus DNQX.
Goettl VM; Larson AA
Brain Res; 1994 Apr; 642(1-2):334-8. PubMed ID: 8032897
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of N-methyl-D-aspartate evoked sodium flux by MK-801.
Ransom RW; Stec NL
Brain Res; 1988 Mar; 444(1):25-32. PubMed ID: 3282615
[TBL] [Abstract][Full Text] [Related]
27. Stereoselective antagonism of NMDA-stimulated noradrenaline release from rat hippocampal slices by MK-801.
Lalies M; Middlemiss DN; Ransom R
Neurosci Lett; 1988 Sep; 91(3):339-42. PubMed ID: 2847087
[TBL] [Abstract][Full Text] [Related]
28. Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats.
Ward L; Mason SE; Abraham WC
Pharmacol Biochem Behav; 1990 Apr; 35(4):785-90. PubMed ID: 2189143
[TBL] [Abstract][Full Text] [Related]
29. Effects of N-methyl-D-aspartate (NMDA) antagonist MK-801 on breathing pattern in rats.
Monteau R; Gauthier P; Rega P; Hilaire G
Neurosci Lett; 1990 Feb; 109(1-2):134-9. PubMed ID: 2156189
[TBL] [Abstract][Full Text] [Related]
30. Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats.
Schmidt WJ; Bubser M
Pharmacol Biochem Behav; 1989 Mar; 32(3):621-3. PubMed ID: 2544900
[TBL] [Abstract][Full Text] [Related]
31. The interaction between MK-801 and receptors for N-methyl-D-aspartate: functional consequences.
Woodruff GN; Foster AC; Gill R; Kemp JA; Wong EH; Iversen LL
Neuropharmacology; 1987 Jul; 26(7B):903-9. PubMed ID: 2821432
[TBL] [Abstract][Full Text] [Related]
32. [3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes.
Wong EH; Knight AR; Woodruff GN
J Neurochem; 1988 Jan; 50(1):274-81. PubMed ID: 2826686
[TBL] [Abstract][Full Text] [Related]
33. Intracerebroventricular application of competitive and non-competitive NMDA antagonists induce similar effects upon rat hippocampal electroencephalogram and local cerebral glucose utilization.
Boddeke HW; Wiederhold KH; Palacios JM
Brain Res; 1992 Jul; 585(1-2):177-83. PubMed ID: 1511299
[TBL] [Abstract][Full Text] [Related]
34. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
Willetts J; Balster RL
J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
[TBL] [Abstract][Full Text] [Related]
35. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
Sato K; Morimoto K; Okamoto M
Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
[TBL] [Abstract][Full Text] [Related]
36. Anticonvulsant effects of antagonists of the N-methyl-D-aspartate receptor complex in a genetic model of epilepsy: the quaking mouse.
Mitrovic N; Besson MJ; Maurin Y
Eur J Pharmacol; 1990 Feb; 176(3):357-61. PubMed ID: 2158455
[TBL] [Abstract][Full Text] [Related]
37. NMDA receptor antagonists and limbic status epilepticus: a comparison with standard anticonvulsants.
Bertram EH; Lothman EW
Epilepsy Res; 1990 Apr; 5(3):177-84. PubMed ID: 2166658
[TBL] [Abstract][Full Text] [Related]
38. Role of N-methyl-D-aspartate (NMDA) receptors in experimental catalepsy in rats.
Mehta AK; Ticku MK
Life Sci; 1990; 46(1):37-42. PubMed ID: 2153885
[TBL] [Abstract][Full Text] [Related]
39. In vivo labelling of the NMDA receptor channel complex by [3H]MK-801.
Price GW; Ahier RG; Middlemiss DN; Singh L; Tricklebank MD; Wong EH
Eur J Pharmacol; 1988 Dec; 158(3):279-82. PubMed ID: 2472964
[TBL] [Abstract][Full Text] [Related]
40. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
Wlaź P; Ebert U; Potschka H; Löscher W
Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
